As the therapeutic biologics organization within Janssen Research & Development, we are leaders in developing biologic solutions for the treatment of challenging and complex diseases, and we aspire to translate scientific discoveries into transformational medicines that will make significant contributions to human health. Through our entrepreneurial culture of innovation, we take unique approaches to exploring and developing new therapeutic platforms to treat unmet medical needs.
We partner with experts in six therapeutic areas—Immunology, Oncology, Neuroscience, Infectious Diseases and Vaccines, Cardiovascular and Metabolism and Pulmonary Hypertension—to provide a strategic balance of technical, scientific and clinical capabilities. We also work closely with Janssen Pharmaceutical Development, Manufacturing Sciences (PDMS) and the Global Regulatory Affairs organization on development and lifecycle management to ensure that high-quality biologic drug products are provided to patients. Such integration and planning across disciplines is critical to success and means that we are involved in every stage of the process.
We provide hands-on, “end-to-end” expertise and guidance throughout the various preclinical and clinical phases and milestones of the biologics discovery and development process. We harness internal expertise along with external innovations to develop a portfolio of more than 50 novel and differentiated biologic drug candidates.